Portal de Periódicos da CAPES

An FKBP‐Rapamycin‐Sensitive, Cyclin‐Dependent Kinase Activity that Correlates with the FKBP‐Rapamycin‐Induced G1 Arrest Point in MG‐63 Cells a

1993; Wiley; Volume: 696; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1993.tb17142.x

1749-6632

Mark W. Albers, Eric J. Brown, Akito Tanaka, Richard T. Williams, Frederick L. Hall, Stuart L. Schreiber,

Neuroblastoma Research and Treatments

Annals of the New York Academy of SciencesVolume 696, Issue 1 p. 54-62 An FKBP-Rapamycin-Sensitive, Cyclin-Dependent Kinase Activity that Correlates with the FKBP-Rapamycin-Induced G1 Arrest Point in MG-63 Cellsa MARK W. ALBERS, MARK W. ALBERS Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorERIC J. BROWN, ERIC J. BROWN Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorAKITO TANAKA, AKITO TANAKA Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorRICHARD T. WILLIAMS, RICHARD T. WILLIAMS Department of Molecular Pharmacology and Toxicology University of Southern California School of Medicine and Pharmacy Los Angeles, California 90054Search for more papers by this authorFREDERICK L. HALL, FREDERICK L. HALL Department of Molecular Pharmacology and Toxicology University of Southern California School of Medicine and Pharmacy Los Angeles, California 90054Search for more papers by this authorSTUART L. SCHREIBER, STUART L. SCHREIBER Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this author MARK W. ALBERS, MARK W. ALBERS Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorERIC J. BROWN, ERIC J. BROWN Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorAKITO TANAKA, AKITO TANAKA Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this authorRICHARD T. WILLIAMS, RICHARD T. WILLIAMS Department of Molecular Pharmacology and Toxicology University of Southern California School of Medicine and Pharmacy Los Angeles, California 90054Search for more papers by this authorFREDERICK L. HALL, FREDERICK L. HALL Department of Molecular Pharmacology and Toxicology University of Southern California School of Medicine and Pharmacy Los Angeles, California 90054Search for more papers by this authorSTUART L. SCHREIBER, STUART L. SCHREIBER Department of Chemistry Harvard University Cambridge, Massachusetts 02138Search for more papers by this author First published: November 1993 https://doi.org/10.1111/j.1749-6632.1993.tb17142.xCitations: 8 a Supported by the National Institutes of Health (GM-38627, awarded to SLS and a Biomedical Research Support Grant to CHLA), the National Science Foundation (DCB-9104769, awarded to FLH), and the John C. Wilson Jr. Endowment (awarded to FLH via Vernon Tolo). MWA is a Howard Hughes Medical Institute predoctoral fellow. RTW is an affiliate of the University of Queensland, Australia. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume696, Issue1Immunosuppressive and Anti‐Inflammatory DrugsNovember 1993Pages 54-62 RelatedInformation